首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal GPR89A/GPR89B Antibody

  • 中文名: GPR89A/GPR89B抗体
  • 别    名: GPHR; GPR89; SH120; GPR89B; GPR89C; UNQ192
货号: IPDX13527
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/20-1/100 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 1/5000-1/10000 Human,Mouse,Rat

产品详情

AliasesGPHR; GPR89; SH120; GPR89B; GPR89C; UNQ192
WB Predicted band size53 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse
ImmunogenSynthetic peptide of human GPR89A/GPR89B
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

参考文献

以下是关于GPR89A/GPR89B抗体的3篇代表性文献的简要概述:

1. **"GPR89A localizes to the Golgi apparatus and modulates its structure"**

- 作者:Smith A et al.

- 摘要:通过使用特异性GPR89A抗体,研究发现该蛋白定位于高尔基体,并参与调控高尔基体膜结构的完整性。抗体验证显示其在HeLa细胞中特异性识别内源性GPR89A。

2. **"Characterization of GPR89B as a pH-sensitive intracellular ion channel"**

- 作者:Lee J et al.

- 摘要:研究利用定制兔源多克隆GPR89B抗体,证实其在细胞内的内质网定位,并揭示其作为pH依赖性氯离子通道的功能。抗体通过免疫印迹和免疫荧光验证了特异性。

3. **"Differential roles of GPR89A and GPR89B in autophagy regulation"**

- 作者:Wang Y et al.

- 摘要:通过商业化GPR89A/B抗体对比实验,发现GPR89A促进自噬体形成,而GPR89B抑制溶酶体降解。研究强调了抗体在区分两种亚型功能差异中的关键作用。

备注:以上文献为示例性内容,实际文献需通过PubMed或SciFinder检索确认。若研究较少,可扩展至GPR89(旧称)相关抗体研究或结构功能分析论文。

背景信息

GPR89A (Golgi pH Regulator) and GPR89B are paralogous proteins belonging to the G protein-coupled receptor (GPCR) superfamily, though their exact functional roles remain unclear. Predominantly localized to the Golgi apparatus, they are implicated in maintaining Golgi luminal pH homeostasis and glycosylation processes. GPR89A is ubiquitously expressed, while GPR89B shows tissue-specific expression, particularly in the brain and gastrointestinal tract. Structurally, they feature multiple transmembrane domains but lack classical GPCR signaling motifs, suggesting atypical mechanisms. Antibodies targeting GPR89A/GPR89B are critical tools for investigating their subcellular distribution, expression patterns, and interactions. These antibodies are widely used in techniques like Western blotting, immunofluorescence, and immunohistochemistry to elucidate their roles in Golgi dysfunction-linked pathologies, such as cancer, neurodegenerative diseases, and metabolic disorders. Recent studies propose GPR89A as a potential biomarker in certain cancers, while GPR89B may influence neurotransmitter regulation. However, challenges persist due to sequence homology between the paralogs, requiring antibody validation via knockout controls. Ongoing research aims to clarify their physiological ligands and downstream signaling, which could unlock therapeutic targeting opportunities for Golgi-associated diseases.

客户数据及评论

折叠内容

大包装询价

×